↓ Skip to main content

Dove Medical Press

Article Metrics

IgG4-related disease: current challenges and future prospects

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
88 Mendeley
Title
IgG4-related disease: current challenges and future prospects
Published in
Therapeutics and Clinical Risk Management, February 2016
DOI 10.2147/tcrm.s99985
Pubmed ID
Authors

David Lang, Jochen Zwerina, Herwig Pieringer

Abstract

Immunoglobulin G4-related disease (IgG4-RD) represents an immune-mediated fibroinflammatory condition with a characteristic histopathological appearance that can affect various organs. Although numerous single-organ manifestations have been described more than a century ago, its systemic nature and unique features were only discovered in the last 2 decades, when IgG4-RD emerged as a new entity of disease. IgG4-RD is usually considered a rare disease, but its true epidemiology has not yet been fully clarified. Also, despite recent advances in the identification of the underlying immunological processes, its pathophysiology is only incompletely understood till now. The diagnostic workup of IgG4-RD is complex and usually requires a combination of clinical examination, imaging, histological, and serological analyses. However, no finding alone is specific for IgG4-RD. Therefore, its diagnosis requires careful interpretation of examination results in context with the patient's clinical appearance as well as the exclusion of a broad variety of differential diagnoses. The past years brought rapid advances concerning this novel disease entity: diagnostic criteria, further insights into the underlying immunological processes, new biomarkers, and novel therapeutic approaches were proposed and widened the knowledge in the field of IgG4-RD. Still, a greater number of questions remain unanswered, and many recent developments require further discussion and proof from clinical trials. This review should give an overview on current knowledge and future perspectives in epidemiology, pathophysiology, diagnosis, and therapy of IgG4-RD.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 87 99%

Demographic breakdown

Readers by professional status Count As %
Other 17 19%
Student > Postgraduate 16 18%
Researcher 11 13%
Student > Master 10 11%
Student > Ph. D. Student 8 9%
Other 20 23%
Unknown 6 7%
Readers by discipline Count As %
Medicine and Dentistry 55 63%
Agricultural and Biological Sciences 6 7%
Immunology and Microbiology 5 6%
Biochemistry, Genetics and Molecular Biology 4 5%
Business, Management and Accounting 3 3%
Other 4 5%
Unknown 11 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2018.
All research outputs
#9,027,954
of 16,636,435 outputs
Outputs from Therapeutics and Clinical Risk Management
#451
of 1,086 outputs
Outputs of similar age
#111,408
of 271,163 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#14
of 52 outputs
Altmetric has tracked 16,636,435 research outputs across all sources so far. This one is in the 45th percentile – i.e., 45% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,086 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,163 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.